Synonyms
|
- LAB4138
- ONKOSIGHT NGS AML PANEL
|
Cerner Name
|
OnkoSight Advanced NGS Rapid AML Panel
|
Clinical Info
|
Tumor sequencing by NGS detecting mutations in 30 genes associated with AML. Mutations often have prognostic significance, may confer
resistance to FDA approved therapies, or may qualify patients for late-stage clinical trials.
|
Specimen Sources
|
Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
Bone Marrow
Bone Marrow Aspirate
|
Specimen Types
|
Aspirate
Blood
Bone Marrow
|
Specimen Volume
|
|
Container
|
Lavender Top Tube
|
Collection Instructions
|
Container/Tube: Lavender top tube
Specimen: 2 mL Bone Marrow or Whole Blood
Alternate Specimens: Bone Marrow - Green Top, Peripheral Blood - Lavender Top,
Peripheral Blood - Green Top, Eppendorf tube, Unstained Slide, Formalin-fixed,
Paraffin-embedded Tissue
Decalcified specimens are not recommended for NGS testing.
Note: Please indicate specimen type
|
Transport Instructions
|
Room Temperature
|
Specimen Stability
|
30 Days Room Temperature or Refrigerated
|
Methodology
|
Genotyping by Next Generation Sequencing
Gene:
ASXL1BRAFBCORCEBPACSFR3DDX41DNMT3AETV6EZH2FLT3GATA2HRASIDH1IDH2JAK2KITKMT2AKRASNF1NPM1NRASPDGFRAPHF6PTPN11RUNX1SETBP1STAG2TET2TP53WT
|
Days Performed
|
TAT: 10 - 12 Days
|
Performing Laboratories
|
GenPath BioReference
Test Code: TL94
|
CPT
|
81450
|
PDM
|
1659925
|
Results
|
| Component Name |
Base Name |
Common Name |
External Name |
| ONCOGENE DX |
ONCOGENE |
ONCOGENE DX |
Onko AML Seq |
| THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS |
THERPROGASS |
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS |
Therapeutic and Prognostic Associations |
| INTERPRETATION SUMMARY |
ONKOSIGHTINT |
INTERPRETATION SUMMARY |
Interpretation Summary |
| DETAILED GENETIC INTERPRETATION 1 |
DETAILGENINT |
DETAILED GENETIC INTERPRETATION 1 |
Detailed Genetic Interpretation 1 |
| DETAILED GENETIC INTERPRETATION 2 : |
DETAILGENINT |
DETAILED GENETIC INTERPRETATION 2 |
Detailed Genetic Interpretation 2 : |
| CLINICAL TRIALS 1 : |
CLINTRIAL |
CLINICAL TRIALS 1 |
Clinical Trials 1: |
| CLINICAL TRIALS 2 : |
CLINTRIAL |
CLINICAL TRIALS 2 |
Clinical Trials 2: |
| TECHNICAL SUMMARY : |
TECHSUM |
TECHNICAL SUMMARY |
Technical Summary: |
| METHODS |
METHODS |
METHODS |
Methods |
| REFERENCES 1 |
REF1 |
REFERENCES 1 |
References 1 |
| REFERENCES 2 |
REF2 |
REFERENCES 2 |
References 2 |
| REPORT FOOTER |
RPTFOOTER |
REPORT FOOTER |
Report Footer |
| ADDENDUM : |
ADDENDUM |
ADDENDUM |
Addendum: |
| ALLELE FREQUENCIES: |
ALLELE |
ALLELE FREQUENCIES |
Allele Frequencies: |
|
Result Interpretation
|
Forms
|
|
